[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"snoezelen\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:snoezelen":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":30,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100608511",false,"NCT07202507","Proof-of-Concept Study of the SNOEZELEN Device on Anxiety Symptoms in Patients Hospitalized for Chemotherapy in a Pediatric Oncology Department","SNOOZE","Inclusion Criteria:\n\n* New patient\n* Treated in the Paediatrics\u002FAJA department of the Oscar Lambret Centre for cancer (all types of cancer)\n* Hospitalisation for several days\n* Highly emetogenic chemotherapy treatment: this corresponds to all in-patient treatments carried out in the Paediatrics\u002FAJA department.\n* Age at diagnosis : ≥ 8 years and \\\u003C 18 years.\n* French language\n* Information for the patient and those with parental authority; consent signed by the patient and those with parental authority.\n* Valid social security cover\n\nExclusion Criteria:\n\n* Contraindication to SNOEZELEN:\n\n  * Claustrophobia\n  * Presence of psychiatric, addictive or cognitive disorders that would prevent compliance with the protocol requirements;\n* State of health not allowing participation in the study (severe fatigue, symptoms refractory to treatment).\n* Pregnant or breast-feeding women","ALL","8 Years","18 Years",{"count":19,"type":20},20,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this clinical trial is to evaluate whether the Snoezelen multisensory relaxation approach can reduce anxiety symptoms in children and adolescents aged 8 to 17 years hospitalized for chemotherapy in a pediatric oncology unit.\n\nResearchers will compare patients' symptoms during a chemotherapy cycle with Snoezelen sessions to a previous cycle without Snoezelen, in order to assess changes in psychological and physical well-being.\n\nParticipants will:\n\n* Be enrolled between their first (without Snoezelen) and second (with Snoezelen) chemotherapy cycles\n* Complete self-report questionnaires on anxiety, depression, quality of life, and nausea\n* Receive 45-minute Snoezelen sessions every two days during their second hospitalization\n* Participate in a semi-structured interview after the final session\n* Provide data on medications (anxiolytics, antiemetics) and vomiting frequency during both hospitalizations",[26,27,28,29],"Snoezelen","Pediatric Cancer","Symptomatologie Anxieuse","Chimiothérapie",[26,27],"RECRUITING","2026-03-16",{"date":34,"type":35},"2026-03-18","ACTUAL",{"date":37,"type":20},"2027-09",{"date":39,"type":20},"2027-10-31",{"name":41,"class":42},"Centre Oscar Lambret","OTHER",""]